Evidence map›Paper›PMID 35335339›Full record

ArticleMolecules (Basel, Switzerland)2022

Garcinia Biflavonoid 1 Improves Lipid Metabolism in HepG2 Cells via Regulating PPARα.

Hai-Xin Chen, Fan Yang, Xin-Qian He, Ting Li, Yong-Zhi Sun, Jian-Ping Song, Xin-An Huang, Wen-Feng Guo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. The Effect of GB1 on DSS-Induced Colitis in WT and Nlrp3International journal of molecular sciences · 2025
    Article
  4. Review
  5. Ethanol extract ofIranian journal of basic medical sciences · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hai-Xin ChenArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Fan YangArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Xin-Qian HeArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID 0000-0002-0833-9872
Ting LiArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Yong-Zhi SunArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Jian-Ping SongArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Xin-An HuangArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID 0000-0003-1628-7416
Wen-Feng GuoArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Guangzhou University of Chinese Medicine · CN

Funding

2021A0505030060 2019-43Science and Technology Project of Guangdong Province 2021A0505030060Special project of international cooperation in TCM of NATCM GZYYGJ2021
6 · The paper itself

Abstract

Garcinia biflavonoid 1 (GB1) is one of the active chemical components of

Indexed as

BiflavonoidsPPAR alphaHep G2 CellsHumansLipid MetabolismBiflavonoidsGarcinia biflavonoid 1PPAR alphafatty acid oxidationgarcinia biflavonoid 1lipid metabolismPPARα

Identifiers

PMID35335339
PMCPMC8950208
OpenAlexW4220892728

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.